Perrigo Company plc $PRGO Shares Acquired by Seven Six Capital Management LLC

Seven Six Capital Management LLC boosted its position in shares of Perrigo Company plc (NYSE:PRGO) by 15.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 382,400 shares of the company’s stock after purchasing an additional 51,600 shares during the period. Perrigo makes up 5.4% of Seven Six Capital Management LLC’s portfolio, making the stock its 8th biggest position. Seven Six Capital Management LLC owned 0.28% of Perrigo worth $5,323,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Geneos Wealth Management Inc. grew its holdings in Perrigo by 439.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after purchasing an additional 786 shares in the last quarter. Kestra Investment Management LLC grew its holdings in Perrigo by 57.1% during the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock valued at $47,000 after purchasing an additional 642 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in Perrigo by 89.1% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,778 shares of the company’s stock valued at $38,000 after purchasing an additional 838 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Perrigo by 116.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock valued at $26,000 after purchasing an additional 1,014 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in Perrigo by 161.5% during the 4th quarter. UMB Bank n.a. now owns 1,964 shares of the company’s stock valued at $27,000 after purchasing an additional 1,213 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Price Performance

Shares of PRGO stock opened at $10.66 on Wednesday. The firm has a market cap of $1.47 billion, a P/E ratio of -0.81, a P/E/G ratio of 1.27 and a beta of 0.51. The company has a debt-to-equity ratio of 1.45, a current ratio of 2.72 and a quick ratio of 1.59. Perrigo Company plc has a 1-year low of $9.23 and a 1-year high of $28.43. The firm has a fifty day moving average of $11.18 and a two-hundred day moving average of $12.41.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.04. The company had revenue of $841.80 million during the quarter, compared to analyst estimates of $1.04 billion. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The firm’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same period last year, the business earned $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, research analysts anticipate that Perrigo Company plc will post 2.11 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Friday, May 29th were given a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 10.9%. The ex-dividend date was Friday, May 29th. Perrigo’s dividend payout ratio (DPR) is presently -8.85%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on PRGO shares. Canaccord Genuity Group lowered their price target on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a report on Friday, February 27th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings raised shares of Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday. Finally, Jefferies Financial Group reissued a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.